2007
DOI: 10.1016/j.fertnstert.2007.07.794
|View full text |Cite
|
Sign up to set email alerts
|

Preimplantation genetic diagnosis of X-linked retinoschisis using multiple displacement amplification (MDA)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2009
2009
2010
2010

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Traditionally, groups with indications for such interventions have included those with high risk of having children with genetic disease who have opted to terminate pregnancies based on prenatal tests, have had recurrent miscarriages, have objections to abortion, and/or who have concurrent infertility and those who are being treated with in-vitro fertilization (IVF) and in whom low rate of success with this method can be attributed to chromosomal aneuploidies in the embryos 8. The uses of this technology have expanded, and reports of its successful use in cases of retinoblastoma and X-linked retinoschisis have been published 9,10…”
Section: Introductionmentioning
confidence: 99%
“…Traditionally, groups with indications for such interventions have included those with high risk of having children with genetic disease who have opted to terminate pregnancies based on prenatal tests, have had recurrent miscarriages, have objections to abortion, and/or who have concurrent infertility and those who are being treated with in-vitro fertilization (IVF) and in whom low rate of success with this method can be attributed to chromosomal aneuploidies in the embryos 8. The uses of this technology have expanded, and reports of its successful use in cases of retinoblastoma and X-linked retinoschisis have been published 9,10…”
Section: Introductionmentioning
confidence: 99%
“…A few clinical applications of MDA resulting in pregnancies in PGD cycles have been reported, such as for X-linked retinoschisis (8), Marfan syndrome (9), Duchenne muscular dystrophy (10), fragile X syndrome (11), cystic fibrosis, and b-thalassemia (12). This is the first report on PGD for HD using whole genome amplification.…”
mentioning
confidence: 99%